The increasing prevalence of cardiac arrhythmias and availability of premium-priced innovative technologies are driving the cardiac ablation market in the United States. Promising technologies – including balloon-based ablation catheters such as cryo-balloons, visually-guided lasers, and radiofrequency balloons – will push the market forward. Image-guidance and mapping technologies are currently under development, some of which are predicted to usher in a new era of effective and personalized atrial fibrillation (AF) care management.
Source: Frost & Sullivan Analysis of the U.S. Cardiac Ablation Market; www.frost.com
Explore the August 2014 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- Boston Scientific to acquire Penumbra, expanding cardiovascular portfolio
- Star Cutter introduces Double Pilot Reamer
- #80 Manufacturing Matters - Machining Strategies to Save Time and Improve your Process for MedTech Components with Kennametal Inc.
- Real-world parts and expert manufacturing advice
- Experts discuss the latest in toolholding technology
- How permanent magnets are powering medical innovation
- Forecasting the year ahead in design and manufacturing
- Tecomet, Orchid Orthopedic Solutions announce merger agreement
